Yes. In someone with G6PD deficiency, oxidants and illness-related oxidative stress can trigger a hemolytic episode, but they do not cause the inherited deficiency itself. These exposures can damage red blood cells, making them break down faster than the body replaces them. This is called hemolysis and can lead to anemia. Common triggers include certain infections, medicines, fava beans, and some chemicals.
How do oxidants affect people with G6PD deficiency?
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme that helps protect red blood cells from damage. These cells carry oxygen throughout the body and need protection from potentially harmful molecules called reactive oxygen species. When these molecules build up beyond the cells' defenses, the resulting imbalance is known as oxidative stress.
According to the U.S. National Library of Medicine's MedlinePlus Genetics, changes in the G6PD gene can reduce the enzyme's protective function. As a result, red blood cells may become more vulnerable to oxidative damage. When enough cells break down, the body may be unable to replace them quickly enough, leading to hemolytic anemia.
G6PD deficiency is inherited, meaning a person is born with it. Oxidants do not create the genetic condition; instead, certain exposures can trigger the destruction of red blood cells in someone who already has the deficiency. Some affected people remain symptom-free throughout their lives, while others experience episodes after particular exposures.
Which oxidants and exposures can trigger hemolysis?
Several types of exposure can increase oxidative stress in people with G6PD deficiency. The relevant trigger depends on the substance or illness and the person's level of G6PD activity. The Merck Manual Professional Edition identifies infections, certain medicines, and substances such as fava beans among the recognized triggers.
- Infections: Bacterial and viral infections can trigger the breakdown of red blood cells. An infection accompanied by fever may be followed by a hemolytic episode.
- Medicines: Certain drugs can have oxidizing effects that damage red blood cells. Examples include some antimalarial medicines, such as primaquine; particular antibiotics, including sulfonamides and nitrofurantoin; dapsone; rasburicase; and methylene blue. The risks differ between medicines, so the exact drug matters.
- Fava beans: Eating fava beans, also called broad beans, can provoke red blood cell breakdown in susceptible people. This reaction is known as favism.
- Certain chemicals: Naphthalene, which may be found in some mothballs, and certain industrial chemicals, including aniline dyes, are recognized potential triggers.
This is not a complete list of every possible trigger. A medicine's name, dose, intended use, and the person's medical circumstances can affect whether it is appropriate. Not every medication within a broad drug group carries the same risk, and a general list should not replace an individualized medication review.
Does every oxidant exposure cause a reaction?
No. Exposure does not automatically lead to hemolysis. The likelihood and extent of red blood cell damage depend partly on the person's remaining G6PD activity and the oxidizing potential of the substance. Different people with the same inherited condition may therefore respond differently to a similar exposure.
It is also important to distinguish harmful oxidant exposures from the many normal chemical processes that occur in the body. The term oxidative stress describes an imbalance between potentially harmful reactive molecules and the body's protective systems. It does not mean that every substance described as an oxidant, or every everyday exposure, will cause a medical problem.
For practical purposes, the priority is to recognize established triggers rather than try to avoid every substance that might produce oxidative stress. A healthcare professional can help identify which medicines, foods, or chemicals are relevant to a particular person's circumstances.
What signs may appear after an oxidant exposure?
When a trigger causes red blood cells to break down, symptoms may develop over the following hours or days, depending on the exposure and individual circumstances. Examples include:
- Urine that looks unusually dark, brown, or tea-colored.
- Yellowing of the skin or the whites of the eyes, known as jaundice.
- Unusual tiredness, weakness, or paleness.
- Shortness of breath or a faster-than-usual heartbeat.
- Abdominal pain or back pain in some cases.
These changes can occur for reasons other than G6PD-related hemolysis, but new symptoms following a suspected trigger deserve prompt medical attention. According to the Cleveland Clinic, rapid or severe symptoms associated with red blood cell breakdown require emergency evaluation. Seek emergency care for significant breathing difficulty, fainting, or rapidly worsening symptoms. Newborns with possible G6PD deficiency also need prompt assessment for jaundice, particularly when yellowing develops in the first days of life.
How can you reduce the risk of an oxidant-triggered episode?
The most useful preventive step is to communicate the diagnosis to every healthcare professional involved in prescribing or dispensing medicines. This includes doctors, pharmacists, dentists, and clinicians providing emergency or hospital care. Knowing about G6PD deficiency allows them to review possible risks before selecting a medicine.
University College London Hospitals NHS Foundation Trust advises people with G6PD deficiency to tell healthcare professionals about the condition before starting a new medicine so its safety can be checked. The appropriate precautions depend on the specific medication and clinical situation.
Additional practical steps include avoiding fava beans when advised for confirmed G6PD deficiency, limiting exposure to recognized harmful chemicals, and seeking appropriate care for infections. Keep an up-to-date list of medicines, supplements, and other products you use, and share it when receiving care.
Do not stop a prescribed medicine, avoid an important treatment, or substitute an over-the-counter product solely because a general online list mentions a drug group. Some commonly used medicines may be suitable for people with G6PD deficiency, while other medicines require specific precautions or alternatives. A qualified clinician or pharmacist can check the exact product and help weigh the risks and benefits.
Can a blood test confirm G6PD deficiency?
A blood test measuring G6PD enzyme activity can help establish whether a person has the deficiency. Testing may be considered when there is a relevant family history, unexplained red blood cell breakdown, or a need to assess risk before using certain medicines.
According to MedlinePlus Medical Test, testing may need to be repeated after a hemolytic episode. During or soon after an episode, a result can sometimes appear normal even when G6PD deficiency is present. A healthcare professional may therefore interpret the test alongside symptoms, medical history, other blood results, and the timing of the exposure.
When symptoms suggest an ongoing episode, medical assessment should not be delayed while waiting for a test. Identifying a potential trigger, evaluating red blood cell destruction, and reviewing current medicines help clinicians decide what care is needed.
What is the main takeaway about oxidants and G6PD deficiency?
Oxidants can trigger red blood cell breakdown in people with G6PD deficiency, but they do not cause the inherited condition itself. Recognized triggers include certain infections, specific medicines, fava beans, and particular chemicals. The risk is not identical for every person or exposure. Knowing the condition, reviewing medicines with a healthcare professional, and responding promptly to possible signs of hemolysis can help reduce avoidable complications.